MMSI MERIT MEDICAL SYSTEMS INC

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business model: design, manufacture, and sell medical devices globally with emphasis on regulatory compliance and product lifecycle management
• • Regulatory challenges heightened by EU MDR certification delays, increased costs, and discontinuation of certain products in the E.U. this fiscal year
• • Strategic shift toward development of increasingly therapeutic medical products requiring more clinical trials, raising innovation risk and regulatory complexity
• • Notable compliance and risk exposure: expanded focus on global anti-bribery laws, extensive healthcare fraud and abuse scrutiny, and evolving privacy/data protection regulations impacting operations
• • Environmental and social governance risks addressed with potential impacts from PFAS and ethylene oxide sterilization restrictions and growing corporate social responsibility requirements

Risk Factors

• • Supply chain reliance on limited sterilization service providers risks production delays if any ceases operation or compliance, potentially halting sales
• • Geopolitical tensions in Ukraine, Middle East, Venezuela increasing supply interruptions, elevating cost pressures on petroleum-based materials critical to manufacturing
• • China’s Value-Based Purchasing (VBP) policy since 2022 negatively impacting pricing and revenue, with continued adverse effects expected in 2026
• • Competition from larger medical device firms and tech entrants with greater AI integration capabilities threatening market share and product relevance
• • CEO transition in Oct 2025 to Martha G. Aronson, with no key man insurance; potential disruption or loss of institutional knowledge poses material business risk

Management Discussion & Analysis

• • Revenue $1.516B in 2025, up 11.8% YoY ($159.4M increase from $1.357B in 2024), driven by U.S. and EMEA demand
• • Gross margin 48.7% in 2025 vs 47.4% in 2024; net income $128.5M (8.5% margin) vs $120.4M (8.9% margin)
• • Best segment: Cardiovascular sales $1.443B (+10.9%), operating income $166.1M; Worst: Endoscopy sales $72.9M (+33.0%), operating income $18.6M
• • Increased SG&A expenses by $55.5M (13.9%) and R&D by $9.9M (11.3%) in 2025; long-term debt $747.5M, contingent liabilities $4.5M, operating leases $87.5M
• • Management highlights multi-year Continued Growth initiatives through 2026; key risks include increased effective tax rate (24.8% vs 19.8%) and foreign currency fluctuations

What are the latest MMSI SEC filings in 2026?

MERIT MEDICAL SYSTEMS INC (MMSI) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on April 30, 2026, an 8-K current report on July 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did MMSI file its most recent 10-K annual report?

MERIT MEDICAL SYSTEMS INC (MMSI) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view MMSI 10-Q quarterly reports?

MERIT MEDICAL SYSTEMS INC (MMSI)'s most recent 10-Q quarterly report was filed on April 30, 2026. SignalX displays every MMSI 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has MMSI filed recently?

MERIT MEDICAL SYSTEMS INC (MMSI)'s most recent 8-K was filed on July 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find MMSI insider trading activity (Form 4)?

SignalX aggregates every MMSI Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does MMSI file with the SEC?

MERIT MEDICAL SYSTEMS INC (MMSI) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new MMSI filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for MERIT MEDICAL SYSTEMS INC (MMSI).

What is MMSI's SEC CIK number?

MERIT MEDICAL SYSTEMS INC (MMSI)'s SEC CIK (Central Index Key) number is 856982. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 856982 to look up all MMSI filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find MMSI return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from MERIT MEDICAL SYSTEMS INC (MMSI) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.